Cresco Labs, Inc. (CRLBF)
0.6438
+0.01
(+1.23%)
USD |
OTCM |
Oct 09, 16:00
Cresco Labs Profit Margin (Quarterly) : 8.87% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.87% |
| March 31, 2026 | -11.24% |
| December 31, 2025 | -55.06% |
| September 30, 2025 | -13.32% |
| June 30, 2025 | -8.49% |
| March 31, 2025 | -9.19% |
| December 31, 2024 | 0.25% |
| September 30, 2024 | -4.28% |
| June 30, 2024 | -27.76% |
| March 31, 2024 | -1.12% |
| December 31, 2023 | 2.59% |
| September 30, 2023 | -59.53% |
| June 30, 2023 | -21.96% |
| March 31, 2023 | -14.32% |
| December 31, 2022 | -90.50% |
| September 30, 2022 | -1.54% |
| Date | Value |
|---|---|
| June 30, 2022 | -3.80% |
| March 31, 2022 | -11.04% |
| December 31, 2021 | -5.47% |
| September 30, 2021 | -122.3% |
| June 30, 2021 | 1.26% |
| March 31, 2021 | -13.52% |
| December 31, 2020 | -25.37% |
| September 30, 2020 | 16.68% |
| June 30, 2020 | -44.24% |
| March 31, 2020 | -53.42% |
| December 31, 2019 | -109.3% |
| September 30, 2019 | -23.74% |
| June 30, 2019 | -13.11% |
| March 31, 2019 | -35.97% |
| December 31, 2018 | -15.37% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| cbdMD, Inc. | -20.30% |
| Trulieve Cannabis Corp. | -149.6% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.52% |
| Return on Assets | -8.95% |
| Return on Invested Capital | -12.69% |
| Gross Profit Margin (Quarterly) | 46.49% |
| Operating Margin (Quarterly) | 12.58% |
| Return on Net Operating Assets | -10.02% |